Contents
Download PDF
pdf Download XML
413 Views
100 Downloads
Share this article
Research Article | Volume 13 Issue:4 (, 2023) | Pages 140 - 147
Evaluate The Risk Factors Associated with Massive Transfusion in Obstetric Hemorrhage at A Tertiary Care Centre
Under a Creative Commons license
Open Access
Received
Sept. 3, 2023
Revised
Sept. 16, 2023
Accepted
Sept. 26, 2023
Published
Oct. 8, 2023
Abstract

Massive transfusion in obstetric catastrophes is to achieve surgical hemostasis while reducing the hypoperfusion complications.Aprospective observational study was conducted on subjects with obstetric hemorrhage requiring blood/blood product transfusions for 405 subjects out of 10063 subjects required transfusion (4.02% incidence).Association between massive transfusion and age ≥35 years was assessed using chi square test P value was <0.001 significant, similarly, irregular antenatal check-up was also found to be significant with P value 0.004. Association between previous LSCS and massive transfusion was found to be P value 0.017 significant and a significant association was found between platelet count & massive transfusion,blood loss & massive transfusion andshock and DIC with a P value of <0.001.

Keywords
Recommended Articles
Research Article
To assess the effectiveness of using either single extra-articular humerus plating or bipillar plating for treating distal humerus fractures in a tertiary care teaching hospital
Published: 22/09/2013
Download PDF
Research Article
Comparative Dosimetric Evaluation of Three Radiotherapy Techniques in Breast Cancer: Impact on Organs at Risk
Published: 16/05/2024
Download PDF
Research Article
Association between apolipoproteins and coronary artery disease (CAD), a case–control observational study
Published: 01/05/2020
Download PDF
Research Article
Evaluation of Quality of Life and Treatment Response Following Quad Shot Radiotherapy in Patients with Locally Advanced or Metastatic Head and Neck Cancer
Published: 14/03/2022
Download PDF
Chat on WhatsApp
Copyright © EJCM Publisher. All Rights Reserved.